Nicola Gebbia
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 10
- Cancer-related Molecular Pathways 9
- Cancer Treatment and Pharmacology 8
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 8
- Geriatrics and Gerontology top 2%
- Hepatology top 5%
- Immunology top 5%
-
- Lung Cancer Treatments and Mutations 9
- Gastric Cancer Management and Outcomes 8
-
- Genetic factors in colorectal cancer 8
-
- Head and Neck Cancer Studies 7
- Co-authors
- Antonio RussoViviana BazanManuela MigliavaccaMarcella MacalusoValentina CalòM BuscemiFabio FulfaroGaetano Leto
- Partner nations
- ItalyUnited StatesArgentina
In The Last Decade
Nicola Gebbia
72 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 2.1k
- Cancer Research 711
- Geriatrics and Gerontology 156
- Hepatology 276
- Immunology 719
Countries citing papers authored by Nicola Gebbia
This map shows the geographic impact of Nicola Gebbia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Gebbia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Gebbia more than expected).
Fields of papers citing papers by Nicola Gebbia
This network shows the impact of papers produced by Nicola Gebbia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Gebbia. The network helps show where Nicola Gebbia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicola Gebbia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 13 | |
| 2 | 2007 | 404 | |
| 3 | 2007 | 23 | |
| 4 | 2005 | 141 | |
| 5 | 2005 | 6 | |
| 6 | 2004 | 23 | |
| 7 | 2003 | 496 | |
| 8 | p53 Mutations in L3-Loop Zinc-binding Domain, DNA-Ploidy, and S Phase Fraction Are Independent Prognostic Indicators in Colorectal Cancer | 2002 | 1 |
| 9 | 2002 | 25 | |
| 10 | 2002 | 20 | |
| 11 | 2001 | 24 | |
| 12 | 1999 | 5 | |
| 13 | 1996 | 2 | |
| 14 | 1995 | 23 | |
| 15 | 1995 | 12 | |
| 16 | 1993 | 6 | |
| 17 | 1992 | 4 | |
| 18 | 1992 | 5 | |
| 19 | 1991 | 4 | |
| 20 | 1988 | 7 |
About Nicola Gebbia
Nicola Gebbia is a scholar working on Otorhinolaryngology, Oncology and Geriatrics and Gerontology, having authored 72 papers that have together received 4.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer-related Molecular Pathways (9 papers), Lung Cancer Treatments and Mutations (9 papers), Protease and Inhibitor Mechanisms (8 papers), Gastric Cancer Management and Outcomes (8 papers), Genetic factors in colorectal cancer (8 papers), Cancer Treatment and Pharmacology (8 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (711 citations) and Geriatrics and Gerontology (156 citations). Nicola Gebbia has collaborated with scholars based in Italy, United States and Argentina. Frequent co-authors include Antonio Russo, Viviana Bazan, Manuela Migliavacca, Marcella Macaluso, Valentina Calò, M Buscemi, Fabio Fulfaro, Gaetano Leto, Francesco Dieli and Nadia Caccamo. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.